文献速递免疫规划传染病防控与疫情报告

麻疹和风疹消除国家接种MMR2后疫苗诱导免疫持续时间

Duration of vaccine-induced immunity following MMR2 vaccination in a measles and rubella-eliminated country.
PubMed 文献 · Int J Epidemiol · 2026-01-01

该研究利用2019年韩国全国血清学调查数据,以年龄作为接种后时间的代理,估计MMR2接种后麻疹、腮腺炎和风疹抗体的衰减率及免疫持续时间。结果显示麻疹、腮腺炎和风疹抗体年均衰减率分别为8.71%、12.02%和5.48%,当不确定结果视为阴性时免疫持续时间分别为19年、9.71年和31.57年。结论提示未经历自然感染者存在年龄依赖的疫苗免疫衰减,高接种率国家仍需持续警惕。

要点

  • MMR2后麻疹、腮腺炎、风疹抗体年均衰减率分别为8.71%、12.02%、5.48%。
  • 不确定结果视为阴性时,免疫持续时间麻疹19年、腮腺炎9.71年、风疹31.57年。
  • 高疫苗覆盖且已消除麻疹风疹的国家仍应持续监测疫苗免疫衰减。

核心结论

  • 未经历自然感染者接种MMR2后疫苗诱导免疫随年龄增长而衰减。
  • 疫苗接种仍是最有效预防手段,但高覆盖国家也需持续警惕。

研究设计与样本

  • 利用2019年韩国全国血清学调查数据,以年龄作为接种MMR2后时间的代理。
  • 韩国自1995年出生队列起MMR2覆盖率超过95%,2001年以来无显著麻疹或风疹暴发,可获得同质队列。

主要发现

  • MMR2接种后麻疹、腮腺炎、风疹抗体平均年衰减率分别为8.71%、12.02%、5.48%。
  • 不确定结果视为阴性时,疫苗诱导免疫持续时间估计为麻疹19年、腮腺炎9.71年、风疹31.57年。
  • 不确定结果视为阳性时,免疫持续时间估计为麻疹27.32年、腮腺炎15.25年、风疹39.77年。

关键数值与推荐

  • 麻疹抗体年衰减率8.71%,腮腺炎12.02%,风疹5.48%。
  • 不确定结果视为阴性时免疫持续时间:麻疹19年,腮腺炎9.71年,风疹31.57年。
  • 不确定结果视为阳性时免疫持续时间:麻疹27.32年,腮腺炎15.25年,风疹39.77年。

临床怎么用

  • 在麻疹和风疹消除地区应关注MMR2接种者随年龄增长的抗体衰减。
  • 腮腺炎疫苗诱导免疫持续时间估计较短,需关注腮腺炎防控。
  • 高疫苗覆盖率国家仍应维持血清学监测和疫情 vigilance。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The measles, mumps, and rubella (MMR) vaccine is generally considered to provide lifelong immunity against measles and rubella. However, occasional measles outbreaks in countries with high vaccine coverage have raised concerns about waning immunity. In this study, we aimed to estimate the duration of vaccine-induced immunity following MMR2 vaccination in settings where measles and rubella have been eliminated. METHODS: Using 2019 national serosurvey data, this study estimated antibody waning (decay) rates for each antigen after MMR2 vaccination, with age as a proxy for time since vaccination. In South Korea, MMR2 coverage has exceeded 95% from the 1995 birth cohort, and no significant measles or rubella outbreaks have occurred since 2001, allowing for homogeneous cohorts. Additionally, the time required for the geometric mean titers of each antibody to reach the seronegative cutoff levels was calculated. RESULTS: The average antibody decay rates for MMR were 8.71%, 12.02%, and 5.48% per year, respectively, after MMR2 vaccination. The duration of vaccine-induced immunity was estimated to be 19 years for measles, 9.71 years for mumps, and 31.57 years for rubella when equivocal results were considered negative. If equivocal results were considered positive, the duration would be 27.32 years for measles, 15.25 years for mumps, and 39.77 years for rubella. CONCLUSION: Here, we found that individuals who have not experienced natural infection exhibited age-dependent waning of vaccine-induced immunity. While vaccination remains the most effective way to prevent disease, continued vigilance is necessary even in countries with high vaccine coverage.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Chun JY, Kim AR, Jeong H, et al. Duration of vaccine-induced immunity following MMR2 vaccination in a measles and rubella-eliminated country. Int J Epidemiol. 2026. PMID: 42201837. doi:10.1093/ije/dyag076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。